Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_assertion type Assertion NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_head.
- NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_assertion description "[We evaluated BCR-ABL expression in CD34(+)CD38(+) (38(+)) committed progenitors and CD34(+)CD38(-) (38(-)) stem/primitive progenitor cells in samples from CML patients on imatinib treatment for at least 4 years with cytogenetic and molecular response.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_provenance.
- NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_assertion evidence source_evidence_literature NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_provenance.
- NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_assertion SIO_000772 21931114 NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_provenance.
- NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_assertion wasDerivedFrom befree-20140225 NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_provenance.
- NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_assertion wasGeneratedBy ECO_0000203 NP287898.RAYxtZbfR5o2BGXxBvmbTFSBCkV6Tv0YDSQrbg64DZ22Y130_provenance.